Psoriasis Clinical Trials

• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients with Chronic Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00096928 - Recruiting
  Psoriasis
  
• Bexarotene with Narrow-Band UVB for Psoriasis
  ClinicalTrials.gov Identifier: NCT00151008 - Active, not recruiting
  Psoriasis
  
• Long-Term Safety Follow-Up Study of Psoriasis Patients
  ClinicalTrials.gov Identifier: NCT00131066 - Active, not recruiting
  - Psoriasis; - Previously enrolled on a MEDI-507 for psoriasis
  
• Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
  ClinicalTrials.gov Identifier: NCT00110981 - Active, not recruiting
  Psoriasis
  
• Study of the Drug Efalizumab (Raptiva), for Adult Patients with Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00115076 - Active, not recruiting
  Psoriasis
  
• To study the effects of CD25 and low dose Cyclosporin in the treatment of active Psoriasis vulgaris
  ClinicalTrials.gov Identifier: NCT00050648 - Active, not recruiting
  Psoriasis
  
• To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00050661 - Active, not recruiting
  Psoriasis
  
• Study to Help Understand the Action of the Drug Etanercept for the Adult Patient with Psoriasis
  ClinicalTrials.gov Identifier: NCT00116181 - Active, not recruiting
  Psoriasis
  
• Conditioning, the Placebo Effect, and Psoriasis
  ClinicalTrials.gov Identifier: NCT00005922 - Active, not recruiting
  Psoriasis
  
• A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Severe Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00267969 - Active, not recruiting
  Psoriasis
  
• Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00581100 - Active, not recruiting
  Nail Psoriasis; Plaque Psoriasis
  
• Phase 2, OPEN-LABEL Study TO EVALUATE CC-10004 RECALCITRANT (NOT RESPONDED TO THERAPY)PLAQUE-TYPE PSORIASIS
  ClinicalTrials.gov Identifier: NCT00521339 - Recruiting
  Recalcitrant Psoriasis; Refractory Psoriasis
  
• Etanercept (Enbrel®) in Psoriasis - Pediatrics
  ClinicalTrials.gov Identifier: NCT00078819 - Active, not recruiting
  Psoriasis
  
• Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy
  ClinicalTrials.gov Identifier: NCT00581555 - Active, not recruiting
  Psoriasis
  
• CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
  ClinicalTrials.gov Identifier: NCT00295425 - Active, not recruiting
  Psoriasis
  
• Evaluate Whether a Course of Methotrexate in Psoriasis Patients Treated With Efalizumab is Safe and Increases Efficacy
  ClinicalTrials.gov Identifier: NCT00368654 - Active, not recruiting
  Psoriasis
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00195676 - Active, not recruiting
  Psoriasis
  
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00235820 - Active, not recruiting
  Psoriasis
  
• A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Moderate to Severe Psoriasis
  ClinicalTrials.gov Identifier: NCT00307437 - Active, not recruiting
  Psoriasis
  
• Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00292396 - Active, not recruiting
  Psoriasis
  
• A Study of the Safety and Effectiveness of CNTO 1275 Compared to Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00454584 - Active, not recruiting
  Psoriasis
  
• Genetic Analysis of Psoriasis and Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00341809 - Active, not recruiting
  Psoriasis
  
• Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness
  ClinicalTrials.gov Identifier: NCT00150930 - Active, not recruiting
  Psoriasis
  
• Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00365625 - Recruiting
  Psoriasis; Psoriasis Vulgaris
  
• A Multicentre, Open Label Phase IIIb Study of Subcutaneously Administered Raptiva in the Treatment of Adult Patients With Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00287118 - Active, not recruiting
  Candidates for Systemic Therapy for Psoriasis
  
• Transitioning from Cyclosporine to Alefacept in Psoriasis
  ClinicalTrials.gov Identifier: NCT00143806 - Active, not recruiting
  Psoriasis
  
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00248456 - Active, not recruiting
  Psoriasis Vulgaris
  
• Etanercept with Tacrolimus for Psoriasis
  ClinicalTrials.gov Identifier: NCT00134394 - Active, not recruiting
  Psoriasis
  
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00263718 - Active, not recruiting
  Psoriasis Vulgaris
  
• An Evaluation of the Efficacy, Safety, Preference and Duration of Response of Clobex (Clobetasol Propionate) Spray vs. Taclonex (Calcipotriene 0.005%/ Betamethasone Dipropionate 0.064%) Ointment in Subjects With Stable Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00437255 - Active, not recruiting
  Psoriasis
  
• Alefacept Mechanism of Action in Psoriasis
  ClinicalTrials.gov Identifier: NCT00150982 - Active, not recruiting
  Psoriasis
  
• Acitretin and Etanercept in Psoriasis
  ClinicalTrials.gov Identifier: NCT00156247 - Recruiting
  Psoriasis
  
• A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00399906 - Recruiting
  Psoriasis
  
• A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00504270 - Recruiting
  Psoriasis
  
• Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
  ClinicalTrials.gov Identifier: NCT00578370 - Recruiting
  Psoriasis
  
• Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
  ClinicalTrials.gov Identifier: NCT00236171 - Recruiting
  Psoriasis Vulgaris
  
• Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.
  ClinicalTrials.gov Identifier: NCT00332332 - Recruiting
  Psoriasis
  
• Safety and Efficacy Study of CF101 to Treat Psoriasis
  ClinicalTrials.gov Identifier: NCT00428974 - Recruiting
  Plaque Psoriasis
  
• Psoriasis Longitudinal Assessment and Registry (PSOLAR)
  ClinicalTrials.gov Identifier: NCT00508547 - Recruiting
  Arthritis, Psoriatic; Psoriasis
  
• Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
  ClinicalTrials.gov Identifier: NCT00408187 - Recruiting
  Psoriasis
  
• PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept
  ClinicalTrials.gov Identifier: NCT00527072 - Recruiting
  Psoriasis
  
• Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
  ClinicalTrials.gov Identifier: NCT00555646 - Recruiting
  Plaque Psoriasis
  
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)
  ClinicalTrials.gov Identifier: NCT00251641 - Recruiting
  Psoriasis
  
• Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
  ClinicalTrials.gov Identifier: NCT00427609 - Recruiting
  Psoriasis
  
• AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects
  ClinicalTrials.gov Identifier: NCT00443326 - Recruiting
  Psoriasis
  
• Subject Preference for Scalp Psoriasis Treatment
  ClinicalTrials.gov Identifier: NCT00438399 - Active, not recruiting
  Scalp Psoriasis
  
• Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271] (P04563)
  ClinicalTrials.gov Identifier: NCT00358670 - Recruiting
  Psoriasis
  
• Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis
  ClinicalTrials.gov Identifier: NCT00372580 - Recruiting
  Psoriasis
  
• A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
  ClinicalTrials.gov Identifier: NCT00513370 - Recruiting
  Psoriasis
  
• Etanercept Plus UVB-311nm Phototherapy in Psoriasis
  ClinicalTrials.gov Identifier: NCT00550030 - Recruiting
  Psoriasis
  
• Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00216892 - Active, not recruiting
  Psoriasis Vulgaris
  
• A Multicentre, Open Label Ph 3b/4 Study of Subcutaneously Admin. Efalizumab (Adult Patients) With Moderate to Severe Chronic Psoriasis Failed to Respond to, or Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Incl. Cyclosporine, M
  ClinicalTrials.gov Identifier: NCT00249808 - Active, not recruiting
  Candidates for Systemic Therapy for Psoriasis
  
• A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent
  ClinicalTrials.gov Identifier: NCT00336973 - Recruiting
  Psoriasis
  
• Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00161655 - Active, not recruiting
  Plaque psoriasis
  
• Role of CD7 in Skin Inflammation and Psoriasis
  ClinicalTrials.gov Identifier: NCT00162825 - Recruiting
  Psoriasis; Inflammation
  
• Pediatric Open-Label Extension Study
  ClinicalTrials.gov Identifier: NCT00141921 - Active, not recruiting
  Pediatric plaque psoriasis
  
• Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
  ClinicalTrials.gov Identifier: NCT00143819 - Recruiting
  Dry skin in psoriasis and eczema
  
• Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
  ClinicalTrials.gov Identifier: NCT00537212 - Recruiting
  Psoriasis; Weight Loss; Diet
  
• PK and PD of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00419666 - Recruiting
  Chronic Plaque Psoriasis
  
• A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.
  ClinicalTrials.gov Identifier: NCT00437619 - Recruiting
  Psoriasis
  
• Fluphenazine Decanoate for Psoriasis
  ClinicalTrials.gov Identifier: NCT00356200 - Recruiting
  Psoriasis
  
• This Study Offers Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.
  ClinicalTrials.gov Identifier: NCT00220025 - Recruiting
  Psoriasis Vulgaris
  
• A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00570986 - Recruiting
  Plaque Psoriasis
  
• Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00227240 - Recruiting
  Plaque Psoriasis
  
• Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
  ClinicalTrials.gov Identifier: NCT00574249 - Recruiting
  Chronic Plaque Psoriasis
  
• Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00184366 - Recruiting
  Plaque Psoriasis
  
• Study of CRx-191 to Assess Activity in Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00557739 - Recruiting
  Plaque Psoriasis
  
• Study Evaluating the Safety and Tolerability of ILV-094 in Subjects With Psoriasis
  ClinicalTrials.gov Identifier: NCT00563524 - Not yet recruiting
  Psoriasis
  
• Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
  ClinicalTrials.gov Identifier: NCT00477191 - Recruiting
  Psoriasis; Metabolic Syndrome; Hyperlipidemia; Obesity; Hypertension
  
• Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-Treated Adults With Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00493324 - Recruiting
  Chronic Plaque Psoriasis
  
• An Observational Study of the Use and Safety of Raptiva during Pregnancy
  ClinicalTrials.gov Identifier: NCT00097240 - Recruiting
  Psoriasis; Pregnancy
  
• Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
  ClinicalTrials.gov Identifier: NCT00395941 - Not yet recruiting
  Psoriasis
  
• The Effectiveness of Lower Cyclosporine Doses for Psoriasis
  ClinicalTrials.gov Identifier: NCT00377325 - Not yet recruiting
  Psoriasis
  
• Optimization of UV Radiation Therapy in Psoriasis
  ClinicalTrials.gov Identifier: NCT00470392 - Not yet recruiting
  Psoriasis
  
• Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis
  ClinicalTrials.gov Identifier: NCT00407979 - Recruiting
  Atopic Dermatitis; Psoriasis
  
• Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00438360 - Recruiting
  Chronic Plaque Psoriasis
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
  ClinicalTrials.gov Identifier: NCT00098189 - Completed
  Psoriasis
  
• Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
  ClinicalTrials.gov Identifier: NCT00001797 - Completed
  Psoriasis
  
• Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00539929 - Not yet recruiting
  Chronic Plaque Psoriasis
  
• Characterizing Serum Protein Patterns in Selected Skin Diseases
  ClinicalTrials.gov Identifier: NCT00063167 - Recruiting
  Psoriasis; Cutaneous T-Cell Lymphoma; Healthy
  
• A Pilot Study of Topical Antiflammin-2 for Psoriasis
  ClinicalTrials.gov Identifier: NCT00001371 - Completed
  Psoriasis
  
• A Study to Evaluate Raptiva in Adults with Moderate to Severe Plaque Psoriasis Who are Candidates for Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00109317 - Completed
  Psoriasis
  
• A Study to Evaluate Raptiva in Combination with Topical Psoriasis Therapies
  ClinicalTrials.gov Identifier: NCT00096980 - Completed
  Psoriasis
  
• Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects with Psoriasis
  ClinicalTrials.gov Identifier: NCT00111449 - Completed
  Psoriasis
  
• Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects
  ClinicalTrials.gov Identifier: NCT00111436 - Completed
  Psoriasis
  
• Efficacy and Safety of Infliximab Therapy in Patients with Psoriasis
  ClinicalTrials.gov Identifier: NCT00106847 - Completed
  Psoriasis
  
• Efficacy and Safety of Infliximab Therapy in Patients with Psoriasis
  ClinicalTrials.gov Identifier: NCT00106834 - Completed
  Psoriasis
  
• An Evaluation of Etanercept in the Treatment of Subjects with Psoriasis
  ClinicalTrials.gov Identifier: NCT00111111 - Completed
  Psoriasis
  
• Community Based Trial for AMEVIVE®
  ClinicalTrials.gov Identifier: NCT00168753 - Active, not recruiting
  Moderate to Severe Chronic Plaque Psoriasis
  
• A Study to Evaluate the Safety of Raptiva in Adults with Plaque Psoriasis Previously Enrolled in Study ACD2600g
  ClinicalTrials.gov Identifier: NCT00096603 - Completed
  Psoriasis
  
• Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
  ClinicalTrials.gov Identifier: NCT00005781 - Completed
  dermatitis; nevus; psoriasis
  
• A Study to Evaluate Raptiva in Adults with Plaque Psoriasis Previously Enrolled in Study ACD2390g
  ClinicalTrials.gov Identifier: NCT00109252 - Completed
  Psoriasis
  
• Safety and Efficacy Study of MM-093 in Patients with Chronic Plaque Psoriasis.
  ClinicalTrials.gov Identifier: NCT00147329 - Completed
  Psoriasis
  
• A Long Term Safety Study of Infliximab (Remicade)
  ClinicalTrials.gov Identifier: NCT00261976 - Active, not recruiting
  Psoriasis; Crohn Disease; Arthritis, Rheumatoid
  
• A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00113542 - Completed
  Psoriasis
  
• Study of Etanercept in the Treatment of Psoriasis in Adult Subjects
  ClinicalTrials.gov Identifier: NCT00121615 - Completed
  Inflammation; Psoriasis
  
• A Phase 4 Trial Assessing CLOBEX Spray, 0.05% When Used as Monotherapy or as Add-on Therapy to Existing Systemic or Topical Anti-Psoriatic Agents.
  ClinicalTrials.gov Identifier: NCT00437216 - Active, not recruiting
  Psoriasis
  
• The Effectiveness Of UVA Light Therapy In The Treatment Of Inflammatory Skin Conditions
  ClinicalTrials.gov Identifier: NCT00129415 - Recruiting
  Atopic Dermatitis; Psoriasis; Alopecia; mycosis fungoides (CTCL); Urticaria; Inflammatory Dermatoses
  
• Study of Topical Calcitriol in Children With Psoriasis
  ClinicalTrials.gov Identifier: NCT00006275 - Completed
  Psoriasis